Zobrazeno 1 - 10
of 239
pro vyhledávání: '"David R Freyer"'
Autor:
Kimberly S Canter, Lee Ritterband, David R Freyer, Martha A Askins, Laura Bava, Caitlyn Loucas, Kamyar Arasteh, Wen You, Anne E Kazak
Publikováno v:
JMIR Research Protocols, Vol 12, p e46339 (2023)
BackgroundThe psychosocial needs and risks of children with cancer and their families are well-documented including increased risk of parental distress, posttraumatic stress, and anxiety. There is a critical need to provide evidence-based psychosocia
Externí odkaz:
https://doaj.org/article/d17df5ad88fe443b94a6025d9a7d1e29
Autor:
Barbara J Turner, Lynn Kysh, Sarah E Piombo, Julia Stal, Dalia Kagramanov, David R Freyer, Kimberly A Miller
Publikováno v:
BMJ Open, Vol 12, Iss 5 (2022)
Introduction Improved treatment regimens have led to increased survival rates among childhood cancer survivors (CCS), and more than 84% of all children diagnosed with cancer will experience long-term survival or cure. Survivors are susceptible to lat
Externí odkaz:
https://doaj.org/article/78938956b4954f9c9f6b0b728094bb79
Autor:
Sarah E. Piombo, Kimberly A. Miller, David R. Freyer, Joel E. Milam, Anamara Ritt-Olson, Gino K. In, Thomas W. Valente
Publikováno v:
Communications Medicine, Vol 2, Iss 1, Pp 1-7 (2022)
Piombo et al. analyse social networks of cancer clinicians to study referral practices to a cancer survivorship clinic at a comprehensive cancer centre. The authors identify key opinion leaders within the networks and suggest interventions to improve
Externí odkaz:
https://doaj.org/article/0276176012e74711ad856c4a19f853c3
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-9 (2022)
Abstract Adolescent and young adult (AYA) enrollment in cancer clinical trials (CCT) is suboptimal. Few studies have explored site level barriers and facilitators to AYA enrollment on CCTs and the efficacy of interventions to enhance enrollment. A cr
Externí odkaz:
https://doaj.org/article/b79ad768b2c049268fb59cda40b55585
Autor:
Karim Thomas Sadak, Milki T. Gemeda, Michelle Grafelman, Joseph P. Neglia, David R. Freyer, Eileen Harwood, Jude Mikal
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-12 (2020)
Abstract Background Adolescent and young adult (AYA) childhood cancer survivors (CCS) should be empowered to continue their survivor-focused care as they transition into adult medicine. However, the majority of AYA-aged survivors become lost to follo
Externí odkaz:
https://doaj.org/article/9e2e01d729d2475eb1a4655b1c7fb35c
Autor:
Michael E. Roth, Joseph M. Unger, Ann M. O'Mara, Mark A. Lewis, Troy Budd, Rebecca H. Johnson, Brad H. Pollock, Charles Blanke, David R. Freyer
Publikováno v:
Cancer Medicine, Vol 9, Iss 6, Pp 2146-2152 (2020)
Abstract Background Few adolescents and young adults (AYAs, 15‐39 years old) enroll onto cancer clinical trials, which hinders research otherwise having the potential to improve outcomes in this unique population. Prior studies have reported that A
Externí odkaz:
https://doaj.org/article/55acfd57bc5d44f6a4fefa5aa18677b3
Autor:
Etan Orgel, Kristin R. Knight, Yueh-Yun Chi, Jemily Malvar, Teresa Rushing, Victoria Mena, Laurie S. Eisenberg, Shahrad R. Rassekh, Colin J.D. Ross, Erika N. Scott, Michael Neely, Edward A. Neuwelt, Leslie L. Muldoon, David R. Freyer
Publikováno v:
Clinical Cancer Research. :OF1-OF9
Purpose: Cisplatin-induced hearing loss (CIHL) is common and permanent. As compared with earlier otoprotectants, we hypothesized N-acetylcysteine (NAC) offers potential for stronger otoprotection through stimulation of glutathione (GSH) production. T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::24fc3a21c721fd467460a97d29a8c53e
https://doi.org/10.1158/1078-0432.ccr-23-0252
https://doi.org/10.1158/1078-0432.ccr-23-0252
Autor:
Eric J. Chow, Sanjeev Aggarwal, David R. Doody, Richard Aplenc, Saro H. Armenian, K. Scott Baker, Smita Bhatia, Nancy Blythe, Steven D. Colan, Louis S. Constine, David R. Freyer, Lisa M. Kopp, Caroline Laverdière, Wendy M. Leisenring, Nao Sasaki, Lynda M. Vrooman, Barbara L. Asselin, Cindy L. Schwartz, Steven E. Lipshultz
Publikováno v:
Journal of Clinical Oncology. 41:2248-2257
PURPOSE For survivors of childhood cancer treated with doxorubicin, dexrazoxane is cardioprotective for at least 5 years. However, longer-term data are lacking. METHODS Within the Children's Oncology Group and the Dana Farber Cancer Institute's Child
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5aa83f6ba1b34a89ce9210ba895b8667
https://doi.org/10.1200/jco.22.02423
https://doi.org/10.1200/jco.22.02423
Autor:
Natasha N. Frederick, James L. Klosky, Lillian Meacham, Gwendolyn P. Quinn, Joanne F. Kelvin, Brooke Cherven, David R. Freyer, Christopher C. Dvorak, Julienne Brackett, Sameeya Ahmed-Winston, Elyse Bryson, H. Irene Su, Eric J. Chow, Jennifer Levine
Publikováno v:
JCO Oncology Practice. 19:e550-e558
PURPOSE: Fertility discussions are an integral part of comprehensive care for pediatric, adolescent, and young adult patients newly diagnosed with cancer and are supported by national guidelines. Current institutional practices are poorly understood.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::98fd663f7c053c4537ae6fc5ab485fc6
https://doi.org/10.1200/op.22.00349
https://doi.org/10.1200/op.22.00349
Autor:
Jordan Gilleland Marchak, Karim T. Sadak, Karen E. Effinger, Regine Haardörfer, Cam Escoffery, Karen E. Kinahan, David R. Freyer, Eric J. Chow, Ann Mertens
Publikováno v:
Journal of Cancer Survivorship. 17:342-350
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::03cbdf71e9507f6fa7f2d7953d6a7492
https://doi.org/10.1007/s11764-023-01351-y
https://doi.org/10.1007/s11764-023-01351-y